American Portfolios Advisors’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-100
Closed -$10.1K 3657
2021
Q4
$10.1K Buy
+100
New +$9.97K ﹤0.01% 2611
2020
Q1
Sell
-90
Closed -$7.07K 2920
2019
Q4
$7.07K Hold
90
﹤0.01% 2144
2019
Q3
$6.16K Hold
90
﹤0.01% 2115
2019
Q2
$7.15K Hold
90
﹤0.01% 2029
2019
Q1
$7.55K Hold
90
﹤0.01% 1938
2018
Q4
$10.6K Hold
90
﹤0.01% 1592
2018
Q3
$10.8K Hold
90
﹤0.01% 1733
2018
Q2
$10.4K Hold
90
﹤0.01% 1709
2018
Q1
$7.73K Hold
90
﹤0.01% 1723
2017
Q4
$6.67K Buy
+90
New +$6.02K ﹤0.01% 1722

Other funds holding USNA

American Portfolios Advisors's USNA Position: Q1 2022 in Review

American Portfolios Advisors sold out of Usana Health Sciences (USNA) in Q1 2022, closing a stake of 100 shares — an estimated $10.1K sold.

American Portfolios Advisors first reported a position in USNA in Q4 2017 and held it in 10 quarters. The position peaked at $10.8K in Q3 2018. 179 funds tracked by Wall St. Rank hold USNA as of Q1 2022.

  • American Portfolios Advisors reported no remaining Usana Health Sciences position as of Q1 2022 after selling out during the quarter.
  • American Portfolios Advisors sold 100 Usana Health Sciences shares in Q1 2022, an estimated $10.1K.
  • American Portfolios Advisors first reported a position in Usana Health Sciences in Q4 2017 and held it in 10 quarters.
  • American Portfolios Advisors's Usana Health Sciences position peaked at $10.8K in Q3 2018.
  • 179 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2022.

Based on American Portfolios Advisors's 13F filing for Q1 2022, filed 21 Mar 2023.